COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 2622: Articles 26211-26220  | Next

Drug-Drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review
Plasencia-Garcia, B. O., Rodriguez-Menendez, G., Rico-Rangel, M. I., Rubio-Garcia, A., Torello-Iserte, J., Crespo-Facorro, B.
10.1101/2020.06.04.20122416 — Posted: 2020-06-08
Sub-weekly cycle uncovers the hidden link of 1atmospheric pollution to Kawasaki Disease
Rodo, X., Navarro Gallinad, A., Kojima, T., Ballester, J., Borras, S.
10.1101/2020.06.04.20122325 — Posted: 2020-06-08
Hawkes process modeling of COVID-19 with mobility leading indicators and spatial covariates
Chiang, W.-H., Liu, X., Mohler, G.
10.1101/2020.06.06.20124149 — Posted: 2020-06-08
Studying the effect of lockdown using epidemiological modelling of COVID-19 and a quantum computational approach using the Ising spin interaction
Padhi, A., Pradhan, S., Sahoo, P. P., Suresh, K., Behera, B. K., Panigrahi, P. K.
10.1101/2020.06.06.20124024 — Posted: 2020-06-08
Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2
Petrak, R., Skorodin, N., Van Hise, N., Fliegelman, R., Pinsky, J., Didwania, V., Anderson, M., Diaz, M., Shah, K., Chundi, V., Hines, D., Harting, B., Sidwha, K., Yu, B., Brune, P., Owaisi, A., Beezhold, D., Kent, J., Vais, D., Han, A., Gowda, N., Sahgal, N., Silverman, J., Stake, J., Nepomuceno, J., Heddurshetti, R.
10.1101/2020.06.05.20122622 — Posted: 2020-06-08
Policy Implications of an Approximate Linear Infection Model for SARS-CoV-2
McCarthy, J. E., Dumas, B. A.
10.1101/2020.06.04.20122549 — Posted: 2020-06-08
SARS-CoV-2 in wastewater treatment plants
Collivignarelli, M. C., Collivignarelli, C., Carnevale Miino, M., Abbà, A., Pedrazzani, R., Bertanza, G.
10.1101/2020.06.04.20122218 — Posted: 2020-06-08
A COVID-19 outbreak in a rheumatology department upon the early days of the pandemic
Romao, V. C., Oliveira-Ramos, F., Cruz-Machado, A. R., Martins, P., Barreira, S., Silva-Dinis, J., Galaio, L., Proenca, H., Melo Cristino, J., Sacadura-Leite, E., Khmelinskii, N., Romeu, J. C., Fonseca, J. E., CHULN Rheumatology Department
10.1101/2020.06.05.20107011 — Posted: 2020-06-08
Associations between COVID-19 infection, tobacco smoking and nicotine use, common respiratory conditions and inhaled corticosteroids: a prospective QResearch-Case Mix Programme data linkage study January-May 2020
Aveyard, P., Lindson, N., Gao, M., Hartmann-Boyce, J., Smith, M., Young, D., Coupland, C., Tan, P. S., Clift, A. K., Harrison, D., Gould, D. W., Pavord, I., Watkinson, P., Hippisley-Cox, J.
10.1101/2020.06.05.20116624 — Posted: 2020-06-08 Discussion: Onsite
Social distancing across vulnerability, race, politics, and employment: How different Americans changed behaviors before and after major COVID-19 policy announcements
Huang, V. S., Sutermaster, S., Caplan, Y., Kemp, H., Schmutz, D., Sgaier, S. K.
10.1101/2020.06.04.20119131 — Posted: 2020-06-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).